DVN
40
-2
MAS
63
3
DIS
72
2
KO
44
2
FITB
72
2
EXR
26
2
NEM
69
-2
HRL
38
3
ALLE
48
2
ETN
61
2
AZO
46
-2
GRMN
40
3
LNC
70
-2
NWL
57
3
MO
57
4
PLD
33
3
COST
53
5
GT
39
2
NEE
52
2
ADM
47
2
DVN
40
-2
MAS
63
3
DIS
72
2
KO
44
2
FITB
72
2
EXR
26
2
NEM
69
-2
HRL
38
3
ALLE
48
2
ETN
61
2
AZO
46
-2
GRMN
40
3
LNC
70
-2
NWL
57
3
MO
57
4
PLD
33
3
COST
53
5
GT
39
2
NEE
52
2
ADM
47
2
Financhill
Back

Catalyst Pharmaceuticals, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
82

CPRX
Catalyst Pharmaceuticals, Inc.

Last Price:
$24.43
Seasonality Move:
6.75%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
82
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.45. The Score for CPRX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals, Inc.'s stock price today?

  • The Catalyst Pharmaceuticals, Inc. share price today is $24.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 64.63 Buy
Chaikin Money Flow: 513481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.83 - 23.99) Buy
Bollinger Bands (100): (19.93 - 22.81) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.1 Buy
20-day SMA: 23.49 Buy
50-day SMA: 22.48 Buy
200-day SMA: 22.19 Buy
8-day EMA: 24.02 Buy
20-day EMA: 23.56 Buy
50-day EMA: 22.37 Buy
200-day EMA: 14.12 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Catalyst Pharmaceuticals, Inc. Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Catalyst Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):